Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A decrease in serum sialyltransferase levels in Alzheimer's disease

T M Maguire1, A M Gillian, D O'Mahony

  • 1Department of Pharmacology, University College, Dublin, Ireland.

Neurobiology of Aging
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Irish national real-world analysis of the clinical and economic impact of 21-gene oncotype DX® testing in early-stage, 1-3 lymph node-positive, oestrogen receptor-positive, HER2-negative, breast cancer.

Breast cancer research and treatment·2024
Same author

Antipsychotic prescribing and drug-related readmissions in multimorbid older inpatients: a post-hoc analysis of the OPERAM population.

International journal of clinical pharmacy·2024
Same author

Healthcare provider perceptions of safety culture: A multi-site study using the safety attitudes questionnaire.

Exploratory research in clinical and social pharmacy·2023
Same author

Hospital physicians' and older patients' agreement with individualised STOPP/START-based medication optimisation recommendations in a clinical trial setting.

European geriatric medicine·2022
Same author

Immune Checkpoint Inhibitors and Palliative Care at the End of Life: An Irish Multicentre Retrospective Study.

Journal of palliative care·2022
Same author

Interprofessional communication in the hospital setting : a systematic review of the qualitative literature.

Journal of interprofessional care·2022
Same journal

Age-related differences in motor learning, sensorimotor neurochemistry, and cortical reactivity co-occur but are dissociated.

Neurobiology of aging·2026
Same journal

How cognition and hearing-related measures covary with hippocampal subfield features from structural MRI in younger and older adults.

Neurobiology of aging·2026
Same journal

Decreased awareness of cognitive decline is associated with multimodal Alzheimer's disease biomarkers in cognitively unimpaired individuals.

Neurobiology of aging·2026
Same journal

Review of current research practices in social and structural determinants of health data collection in Canadian longitudinal cohorts of aging and dementia.

Neurobiology of aging·2026
Same journal

Global brain maintenance predicts well-preserved cognitive function: A pooled analysis of three longitudinal population-based Swedish cohorts.

Neurobiology of aging·2026
Same journal

Midlife insulin resistance and brain beta-amyloid accumulation as predictors of change in late-life cognitive function - A 20-year follow-up study.

Neurobiology of aging·2026
See all related articles

Researchers identified a significant decrease in serum sialyltransferase enzyme levels in Alzheimer

Area of Science:

  • Neuroscience
  • Biochemistry
  • Gerontology

Background:

  • Alzheimer's disease (AD) diagnosis and management require reliable early biomarkers.
  • Current diagnostic methods for AD can be invasive or lack sensitivity for early detection.
  • Understanding peripheral biochemical changes associated with neurodegeneration is crucial.

Purpose of the Study:

  • To investigate serum sialyltransferase levels as a potential early diagnostic marker for Alzheimer's disease.
  • To explore the relationship between serum sialyltransferase activity and age-related neurodegeneration, including in Down's syndrome.
  • To assess the utility of sialyltransferase as a peripheral marker for neurodegenerative processes.

Main Methods:

  • Serum samples were collected from Alzheimer's disease patients, age-matched elderly controls, and young controls.

Related Experiment Videos

  • Serum sialyltransferase enzyme activity was measured and compared across the different groups.
  • Down's syndrome patients with age-related AD pathology were included to study age-related enzyme changes.

    • Main Results:

    • A significant decrease in serum sialyltransferase levels was observed in Alzheimer's disease patients compared to both young and elderly controls.
    • In Down's syndrome patients, serum sialyltransferase activity showed an age-related decline from 20 to 60 years, mirroring levels seen in AD patients.
    • These findings suggest a correlation between reduced serum sialyltransferase and Alzheimer's disease pathology.

    Conclusions:

    • Reduced serum sialyltransferase levels may serve as a valuable peripheral early biochemical marker for Alzheimer's disease.
    • The observed decrease in enzyme activity could indicate underlying cellular events during neurodegeneration in AD.
    • Further research into sialyltransferase's role may enhance early AD detection and therapeutic strategies.